Maravai LifeSciences Holdings, Inc. MRVI Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s operating lease right-of-use asset amortization?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported operating lease right-of-use asset amortization of $1.61M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s operating lease right-of-use asset amortization decreased by 26.6% year-over-year, from $2.19M to $1.61M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s operating lease right-of-use asset amortization?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s operating lease right-of-use asset amortization has grown at a 0.5% compound annual growth rate (CAGR), from $8.79M to $8.96M.